Re-Engineering of Yohimbine’s Biological Activity through Ring Distortion: Identification and Structure–Activity Relationships of a New Class of Antiplasmodial Agents
Open Access
- 16 January 2020
- journal article
- research article
- Published by American Chemical Society (ACS) in ACS Infectious Diseases
- Vol. 6 (2) , 159-167
Abstract
Select natural products are ideal starting points for ring distortion, or the dramatic altering of inherently complex molecules through short synthetic pathways, to generate an array of novel compounds with diverse skeletal architectures. A major goal of our ring distortion approach is to re-engineer the biological activity of indole alkaloids to identify new compounds with diverse biological activities in areas of significance to human health and medicine. In this study, we re-engineered the biological activity of the indole alkaloid yohimbine through ring rearrangement and ring cleavage synthesis pathways to discover new series of antiplasmodial agents. One new compound, Y7j, was found to demonstrate good potency against chloroquine-resistant Plasmodium falciparum Dd2 cells (EC50 = 0.33 µM) without eliciting cytotoxicity against HepG2 cells (EC50 > 40 µM). Y7j demonstrated stage specific action against parasites at the late ring/trophozoite stage. A series of analogues was synthesized to gain structure-activity relationship insights and we learned that both benzyl groups of Y7j are required for activity and fine-tuning of antiplasmodial activities could be accomplished by changing substitution patterns on the benzyl moieties. This study demonstrates the potential for ring distortion to drive new discoveries and change paradigms in chemical biology and drug discovery.Keywords
Funding Information
- National Institute of General Medical Sciences (R35GM128621)
This publication has 42 references indexed in Scilit:
- New developments in anti-malarial target candidate and product profilesMalaria Journal, 2017
- Natural Products as Sources of New Drugs from 1981 to 2014Journal of Natural Products, 2016
- Spread of Artemisinin Resistance in Plasmodium falciparum MalariaNew England Journal of Medicine, 2014
- Antimalarial drug discovery — approaches and progress towards new medicinesNature Reviews Microbiology, 2013
- How were new medicines discovered?Nature Reviews Drug Discovery, 2011
- Expanding the Antimalarial Drug Arsenal—Now, But How?Pharmaceuticals, 2011
- WHO urges the phasing out of artemisinin based monotherapy for malaria to reduce resistance2011
- Impact of high-throughput screening in biomedical researchNature Reviews Drug Discovery, 2011
- Natural Products and Their Biological Targets: Proteomic and Metabolomic Labeling StrategiesAngewandte Chemie International Edition, 2010
- The dynamics of mutations associated with anti-malarial drug resistance in Plasmodium falciparumTrends in Parasitology, 2009